Departments of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, the University of Utah Health Sciences Center, Salt Lake City, Utah, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, the University of Texas Medical Branch, Galveston, Texas, the University of Pittsburgh, Pittsburgh, Pennsylvania, Brown University, Providence, Rhode Island, the University of Texas Health Science Center at Houston and Children's Memorial Hermann Hospital, Houston, Texas, Columbia University, New York, New York, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, The Ohio State University, Columbus, Ohio, the University of Pennsylvania, Philadelphia, Pennsylvania, the University of Alabama at Birmingham, Birmingham, Alabama, and the University of Texas at Austin, Austin, Texas; the George Washington University Biostatistics Center, Washington, DC; and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Corresponding author: William A. Grobman, MD, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH; email: [email protected].
This work is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1 HD087230, UG1 HD027869, UG1 HD027915, UG1 HD034208, UG1 HD040500, UG1 HD040485, UG1 HD053097, UG1 HD040544, UG1 HD040545, UG1 HD040560, UG1 HD040512, UG1 HD087192, U10 HD036801) and the National Center for Advancing Translational Sciences (UL1TR001873). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Financial Disclosure: Torri D. Metz disclosed receiving payment from UpToDate (royalties for two topics on trial of labor after cesarean). Money was paid to her institution from Gestvision (site PI for preeclampsia point-of-care test; institution received money to conduct study [ended August 2020])and Pfizer (site PI for Phase III respiratory syncytial virus [RSV] vaccine trial, institution received money to conduct study). She is a member of medical advisory board for Pfizer and site PI for a COVID-19 vaccination trial in pregnancy Society for Maternal-Fetal Medicine Board of Directors (unpaid). Brenna L. Hughes disclosed receiving payment from Merck, UpToDate, and Johns Hopkins. The other authors did not report any potential conflicts of interest.
*A full list of the members of the NICHD MFMU Network is available in Appendix 1 online at https://links.lww.com/AOG/D119.
Torri D. Metz, deputy editor (Obstetrics) of Obstetrics & Gynecology, was not involved in the review or decision to publish this article.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/D120.
